Robert Schier

Active Investor

Managing Director and Owner

Perroy, Switzerland

Robert Schier, Managing Director and Owner is an active investor based in Perroy, Switzerland. This profile covers what Robert Schier backs, at which stage, and how founders can reach out in 2026.

Dr. Robert Schier serves as Senior Investment Director, Life Tech at Swisscanto Private Equity. He serves as Senior Investment Director and Board Member at Nagi Bioscience. He also serves as Board Member at EcoRobotix. He serves as Board Member at OncoDNA and Memo Therapeutics. He served as Venture Partner at Seventure Partners. He served as a Board Member at MedTrace and Glycemicon. He served as Vice Chairman at Creoptix. His time is dedicated to the coverage of the German and Austrian Life Sciences community on behalf of Seventure, and to prospecting new investment opportunities based there. He serves as Board Member at Versantis. Prior to joining Seventure, he was Partner and Investment Director at Inventages Venture Capital, a life sciences venture capital firm dedicated to nutrition, pharmaceuticals, and enabling technologies in healthcare. During his engagement with Inventages, he invested in more than ten companies in Europe and the US and served as a non-executive director on the boards of many Inventages portfolio companies. He served as Board Member at Versantis and SelectX Pharmaceuticals. He serves as a Director and Board Member at OncoDNA. He served as Board Member at Humedics. He serves as Board Member at Memo Therapeutics.

Investor type: Angel
Stages: Early Stage Venture
Invests in: Biotech & Pharma
Location: Perroy, Switzerland
Typical check: $500K
Past investments: 7

Notable investments

Xerion Pharmaceuticals AGOpsona TherapeuticsGlycemiconBridging Minds SàrlVCH Equity Group AGAsset Management Zürcher KantonalbankAtonomics A/S

How to reach Robert Schier

Angels and operators like Robert Schier reply to specific, personalized notes that show real traction, not mass blasts. Build a verified list, write a note that fits their thesis, and track replies, all on Round Funded.